title: IFN-gamma restores HIV- and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS.
abstract: The addition of IFN-gamma to cultures of peripheral blood mononuclear cells (PBMCs) obtained from asymptomatic HIV-infected patients increased cell proliferation in response to HIV envelope synthetic peptides (Env), influenza A virus (VIRUS), and allogeneic lymphocytes (ALLO) but not to phytohaemagglutinin (PHA) stimulation. F(Ab)2 fragments of IgG purified from the sera of HIV-seropositive patients specifically interfered with IFN-gamma-induced cell proliferation in response to recall antigens. Neutralization of the lymphokine activity was found to be sustained by specific IFN-gamma antibodies. Data obtained demonstrate that IFN-gamma can restore the cell-mediated immunity of a number of asymptomatic HIV+ individuals in vitro, while IFN-gamma antibodies present in sera of patients with AIDS interfere with the activity of the lymphokine.
authors.affiliation: Insitute of Microbiology, University of Brescia, Italy.
authors.forename: M A
authors.initials: MA
authors.lastname: De Francesco
authors.forename: A
authors.initials: A
authors.lastname: Caruso
authors.forename: F
authors.initials: F
authors.lastname: Dima
authors.forename: A
authors.initials: A
authors.lastname: Cantalamessa
authors.forename: A D
authors.initials: AD
authors.lastname: Canaris
authors.forename: S
authors.initials: S
authors.lastname: Folghera
authors.forename: S
authors.initials: S
authors.lastname: Fiorentini
authors.forename: G
authors.initials: G
authors.lastname: Flamminio
authors.forename: S
authors.initials: S
authors.lastname: Licenziati
authors.forename: L
authors.initials: L
authors.lastname: Peroni
authors.forename: J
authors.initials: J
authors.lastname: Gao
authors.forename: G
authors.initials: G
authors.lastname: Garotta
authors.forename: A
authors.initials: A
authors.lastname: Turano
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000276:immunology*; D015483:HIV Antibodies / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000494:pharmacology; D015658:HIV Infections / Q000276:immunology*; D018023:HIV Seronegativity / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007140:Immunoglobulin Fab Fragments / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D009980:Influenza A virus / Q000276:immunology; D007371:Interferon-gamma / Q000276:immunology*; D007519:Isoantigens / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000494:pharmacology; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007519:Isoantigens; D010446:Peptide Fragments; D011994:Recombinant Proteins; D007371:Interferon-gamma